Double Medical Technology Inc. (002901.SZ)
CNY 34.11
(-1.64%)
CNY 34.11
(-1.64%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.42 Billion CNY | 71.98% |
| 2022 | 830.87 Million CNY | 4.98% |
| 2021 | 791.47 Million CNY | 57.14% |
| 2020 | 503.65 Million CNY | 3.78% |
| 2019 | 485.31 Million CNY | 134.2% |
| 2018 | 207.22 Million CNY | 38.33% |
| 2017 | 149.8 Million CNY | 7.82% |
| 2016 | 138.93 Million CNY | 16.23% |
| 2015 | 119.53 Million CNY | -55.88% |
| 2014 | 270.92 Million CNY | 278.5% |
| 2013 | 71.57 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 1.2 Billion CNY | -2.02% |
| 2024 Q1 | 1.39 Billion CNY | -2.63% |
| 2024 Q2 | 1.22 Billion CNY | -11.8% |
| 2023 Q2 | 1.12 Billion CNY | 31.7% |
| 2023 FY | 1.42 Billion CNY | 71.98% |
| 2023 Q4 | 1.42 Billion CNY | 10.52% |
| 2023 Q3 | 1.29 Billion CNY | 15.39% |
| 2023 Q1 | 850.8 Million CNY | 2.4% |
| 2022 Q2 | 767.13 Million CNY | 19.81% |
| 2022 Q1 | 640.29 Million CNY | -19.1% |
| 2022 FY | 830.87 Million CNY | 4.98% |
| 2022 Q4 | 830.87 Million CNY | 14.13% |
| 2022 Q3 | 728.01 Million CNY | -5.1% |
| 2021 Q2 | 725.68 Million CNY | 47.29% |
| 2021 Q3 | 650.07 Million CNY | -10.42% |
| 2021 Q4 | 791.47 Million CNY | 21.75% |
| 2021 Q1 | 492.67 Million CNY | -2.18% |
| 2021 FY | 791.47 Million CNY | 57.14% |
| 2020 Q4 | 503.65 Million CNY | 8.22% |
| 2020 FY | 503.65 Million CNY | 3.78% |
| 2020 Q1 | 421.01 Million CNY | -13.25% |
| 2020 Q2 | 715.57 Million CNY | 69.96% |
| 2020 Q3 | 465.4 Million CNY | -34.96% |
| 2019 FY | 485.31 Million CNY | 134.2% |
| 2019 Q4 | 485.31 Million CNY | 26.63% |
| 2019 Q3 | 383.24 Million CNY | 30.61% |
| 2019 Q2 | 293.43 Million CNY | 45.67% |
| 2019 Q1 | 201.43 Million CNY | -2.79% |
| 2018 Q2 | 157.27 Million CNY | 18.53% |
| 2018 FY | 207.22 Million CNY | 38.33% |
| 2018 Q4 | 207.22 Million CNY | 22.39% |
| 2018 Q3 | 169.31 Million CNY | 7.65% |
| 2018 Q1 | 132.69 Million CNY | -11.42% |
| 2017 Q4 | 149.8 Million CNY | 31.18% |
| 2017 FY | 149.8 Million CNY | 7.82% |
| 2017 Q1 | - CNY | -100.0% |
| 2017 Q2 | 102.54 Million CNY | 0.0% |
| 2017 Q3 | 114.19 Million CNY | 11.36% |
| 2016 FY | 138.93 Million CNY | 16.23% |
| 2016 Q4 | 138.93 Million CNY | 0.0% |
| 2015 FY | 119.53 Million CNY | -55.88% |
| 2014 FY | 270.92 Million CNY | 278.5% |
| 2013 FY | 71.57 Million CNY | 0.0% |